S&P 500 7,431.46 +0.50% NASDAQ 25,888.84 +0.31% DOW 51,202.26 +0.70% R2K 2,943.99 +0.79% VIX 17.68 -9.05% US 10Y 4.49 +0.54% DXY 99.75 -0.11% GOLD 4,215.00 +3.05% CRUDE 84.88 -3.23% BITCOIN 63,784.07 +0.38%
Next Bullish Trade
DHR Danaher Corporation NYQ
$180.10 -0.69 (-0.38%)
Neutral · +0.14σ
+ Compare Set alert Open in Sniper

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $6.0B $1.0B $1.3B $1.1B 17.3% 22.6%
2025-12-31 $6.8B $1.2B $1.5B $1.7B 17.5% 22.0%
2025-09-30 $6.1B $0.9B $1.2B $1.4B 15.0% 19.1%
2025-06-30 $5.9B $0.6B $0.8B $1.1B 9.3% 12.8%
2025-03-31 $5.7B $1.0B $1.3B $1.1B 16.6% 22.2%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%
2024-09-30 $nanB $nanB $nanB $nanB nan% nan%

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-04-21 2.06 1.94 +6.5%
2026-01-28 2.23 2.19 +2.0%
2025-10-21 1.89 1.72 +9.8%
2025-07-22 1.80 1.64 +9.5%
2025-04-22 1.88 1.64 +14.4%
2025-01-29 2.14 2.16 -1.1%
2024-10-22 1.71 1.57 +8.9%
2024-07-23 1.72 1.57 +9.3%
2024-04-23 1.92 1.71 +12.4%
2024-01-30 2.09 1.91 +9.2%
2023-10-24 2.02 1.88 +7.5%
2023-07-25 2.05 2.02 +1.7%
2023-04-25 2.36 2.26 +4.4%
2023-01-24 2.87 2.55 +12.6%
2022-10-20 2.56 2.25 +13.5%
2022-07-21 2.76 2.34 +18.1%
2022-04-21 2.76 2.66 +3.6%
2022-01-27 2.69 2.54 +6.0%
2021-10-21 2.39 2.15 +11.0%
2021-07-22 2.46 2.05 +20.0%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
DHR ★ $127B 34.8 19.5 5.1 17.8 2.4 59.0% 3.7% 9.8% 3.58%
LLY $1,010B 40.3 25.5 14.0 28.9 32.4 82.8% 55.5% 169.9% 0.91%
UNH $371B 30.8 19.5 0.8 19.8 3.8 18.8% 2.0% 0.7% 4.77%
JNJ $580B 27.9 18.9 6.0 17.9 7.1 68.0% 9.9% -52.9% 2.16%
MRK $294B 33.5 12.4 4.5 11.4 6.4 76.7% 4.9% — 4.78%
ABBV $402B 111.1 14.0 6.4 15.6 -60.5 72.0% 12.4% -46.2% 5.17%
PFE $149B 20.0 9.3 2.4 7.9 1.7 74.8% 5.4% -10.1% 8.29%
TMO $174B 25.8 17.2 3.9 19.0 3.3 40.9% 6.2% 11.3% 3.17%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 32.83%

HolderShares% out
Blackrock Inc. 51,640,619 7.30%
Vanguard Capital Management LLC 41,127,810 5.81%
State Street Corporation 27,894,181 3.94%
FMR, LLC 22,534,329 3.18%
JPMORGAN CHASE & CO 16,917,649 2.39%
Price (T.Rowe) Associates Inc 15,352,887 2.17%
Wellington Management Group, LLP 14,774,524 2.09%
Geode Capital Management, LLC 14,145,758 2.00%
Capital International Investors 14,014,713 1.98%
Vanguard Portfolio Management LLC 13,954,705 1.97%

Insider activity · 90d

14 buys / 0 sells · ratio 14.0 · Finnhub

  • Lamanna Charles W BUY 1,699
  • Lamanna Charles W BUY 1,359
  • Couchara Georgeann F 8,291 @ $161.91
  • Sanders A Shane BUY 1,699
  • Sanders A Shane BUY 5,914
  • Stevens Raymond C BUY 1,699
  • Stevens Raymond C BUY 13,728
  • List Teri BUY 1,699
  • List Teri BUY 21,470
  • Dewan Feroz BUY 1,699

Analyst estimates

Finnhub
Low
$200.0
Mean
$242.34782
High
$310.0
Analysts
23
Recommendation distribution · period 2026-06-01
11
16
3
Revision trend (2026-03-01 → 2026-06-01): net 26 → 27 +1 (net = strong_buy+buy − sell−strong_sell)

SEC filings

FormFiled DescriptionAction
8-K 2026-06-03 8-K view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
4 2026-05-19 FORM 4 view ·
8-K 2026-05-07 8-K view ·
4 2026-05-04 FORM 4 view ·
8-K 2026-04-29 8-K view ·
4 2026-04-28 FORM 4 view ·
4 2026-04-28 FORM 4 view ·
4 2026-04-28 FORM 4 view ·
4 2026-04-28 FORM 4 view ·
4 2026-04-28 FORM 4 view ·
4 2026-04-28 FORM 4 view ·
4 2026-04-28 FORM 4 view ·
8-K 2026-04-21 8-K view ·
10-Q 2026-04-21 10-Q view ·
8-K 2026-04-17 8-K view ·
DEF 14A 2026-03-25 DEF 14A view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-03-03 FORM 4 view ·
4 2026-02-27 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
10-K 2026-02-24 10-K view ·
4 2026-02-20 FORM 4 view ·
8-K 2026-02-17 8-K view ·
8-K 2026-02-10 8-K view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-02-04 FORM 4 view ·
4 2026-02-04 FORM 4 view ·
4 2026-02-04 FORM 4 view ·
4 2026-02-04 FORM 4 view ·
4 2026-02-04 FORM 4 view ·
4 2026-02-04 FORM 4 view ·

About

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and character…